The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
 

Editor

Share

Personal info

View

Links

Table of contents

About

Terms

 

Jacques E. Rossouw

National Heart

Lung, and Blood Institute

Rockledge 2 Bldg

[email]@nih.gov

Name/email consistency: high

 
 
 
 
 
 
 

Affiliations

  • National Heart, Lung, and Blood Institute, Rockledge 2 Bldg. 2011 - 2012
  • Women's Health Initiative Branch, Division of Prevention and Population Sciences, National Heart, Lung, and Blood Institute, USA. 1999 - 2008

References

  1. Relationships of coronary heart disease with 27-hydroxycholesterol, low-density lipoprotein cholesterol, and menopausal hormone therapy. Rossouw, J.E., Prentice, R.L., Manson, J.E., Aragaki, A.K., Hsia, J., Martin, L.W., Kuller, L., Johnson, K.C., Eaton, C., Jackson, R., Trevisan, M., Allison, M., Hoogeveen, R.C. Circulation (2012) [Pubmed]
  2. Tissue Factor Pathway Inhibitor, Activated Protein C Resistance, and Risk of Ischemic Stroke due to Postmenopausal Hormone Therapy. Rossouw, J.E., Johnson, K.C., Pettinger, M., Cushman, M., Sandset, P.M., Kuller, L., Rosendaal, F., Rosing, J., Wasserthal-Smoller, S., Martin, L.W., Manson, J.E., Lakshminarayan, K., Merino, J.G., Lynch, J. Stroke (2012) [Pubmed]
  3. Estrogen receptor polymorphisms and the vascular effects of hormone therapy. Rossouw, J., Bray, P., Liu, J., Kooperberg, C., Hsia, J., Lewis, C., Cushman, M., Bonds, D., Hendrix, S., Papanicolaou, G., Howard, T., Herrington, D. Arterioscler. Thromb. Vasc. Biol. (2011) [Pubmed]
  4. Inflammatory, lipid, thrombotic, and genetic markers of coronary heart disease risk in the women's health initiative trials of hormone therapy. Rossouw, J.E., Cushman, M., Greenland, P., Lloyd-Jones, D.M., Bray, P., Kooperberg, C., Pettinger, M., Robinson, J., Hendrix, S., Hsia, J. Arch. Intern. Med. (2008) [Pubmed]
  5. Postmenopausal hormone therapy and risk of cardiovascular disease by age and years since menopause. Rossouw, J.E., Prentice, R.L., Manson, J.E., Wu, L., Barad, D., Barnabei, V.M., Ko, M., LaCroix, A.Z., Margolis, K.L., Stefanick, M.L. JAMA (2007) [Pubmed]
  6. Implications of recent clinical trials of postmenopausal hormone therapy for management of cardiovascular disease. Rossouw, J.E. Ann. N. Y. Acad. Sci. (2006) [Pubmed]
  7. Coronary heart disease in menopausal women: implications of primary and secondary prevention trials of hormones. Rossouw, J.E. Maturitas (2005) [Pubmed]
  8. Hormones, genetic factors, and gender differences in cardiovascular disease. Rossouw, J.E. Cardiovasc. Res. (2002) [Pubmed]
  9. Effect of postmenopausal hormone therapy on cardiovascular risk. Rossouw, J.E. J. Hypertens. Suppl (2002) [Pubmed]
  10. Hormone replacement therapy and cardiovascular disease. Rossouw, J.E. Curr. Opin. Lipidol. (1999) [Pubmed]
 
WikiGenes - Universities